ICDD
Home About Agenda Speakers Register Location Committee
February 22 & 23, 2016 • Austin, Texas

The University of Texas at Austin College of Pharmacy Division of Pharmaceutics and the distinguished members of the Planning Committee welcomes you to the 54th annual International Conference on Drug Development (ICD2), February 22 & 23, 2016 at the Omni Barton Creek Resort and Conference Center in Austin, Texas, USA.

ICD2 continues its tradition of offering an informal forum for the exchange of ideas concerning the drug discovery and drug development process.

The conference brings together national and international scientists from academia, the pharmaceutical industry, the biotechnology industry and regulatory agencies for the opportunity to learn of and discuss new initiatives for finding a better way to develop new drugs as well as to improve the quality of existing drug products.

"I have found it one of the most impactful conferences that I attend." 
Janet Woodcock, M.D.
Director of the Center for Drug Evaluation and Research,
US Food and Drug Administration

Conference Mission:
To offer the most informative and up to date conference in the science and regulation of global drug development


Location: Barton Creek Conference Center • Austin, Texas


"If there’s any person who’s involved in any way with or wants to know about regulatory issues that are facing the industry, they ought to be at this meeting."
Gerald J. Yakatan, Ph.D.
Founder & Chairman, IriSys, Inc.

"The tremendous strengths of the ICD2 is the fact that you have top people from the FDA, top people from industry, top people from other organizations, the legal groups, academic institutions all getting together and really trying to hash out some of the major challenges that the industry and the environment is dealing with and find ways to move forward." 
Kenneth I. Kaitin, Ph.D. 
Professor and Director, Tufts Center for the Study of Drug Development, Tufts University


Target Audience

This conference is intended for leaders in Academia, the Pharmaceutical and Biotechnology Industry (PhRMA, BIO, GPhA), contract research organizations, API manufacturers, and domestic and international regulatory agencies in positions to affect the science and regulation of drug discovery and development, who wish to stay abreast on the national and international initiatives affecting the development of safe and effective pharmaceutical drug products.

Last Reviewed: July 26, 2015

ACPE The University of Texas at Austin College of Pharmacy is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.
Comments to: UTPharmacyCE@austin.utexas.edu
Download free PDF Reader | Download free MS Reader
Privacy Policy | Accessibility Policy
©2012 College of Pharmacy, The University of Texas at Austin
Make a Gift